The shortage of pediatric cancer drugs is a growing concern for families and healthcare providers, with critical medications, like injectable methotrexate and leucovrin, increasingly hard to obtain for children diagnosed with leukemia, USA Today reported Oct. 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
